MIRA Pharmaceuticals, Inc.
MIRA • NASDAQ
MIRA Pharmaceuticals, Inc. is a drug manufacturers - general company in the healthcare sector trading on NASDAQ, led by CEO Erez Aminov, with a market cap of $46.2M.
Market Cap$46.2M
Employees6.0
CEOErez Aminov
CountryUnited States of America
Healthcare
Drug Manufacturers - General
Next EarningsJun 3, 2026 · in a monthBefore Market Open · Q1 2026
Financials
MIRA Pharmaceuticals, Inc. FAQ
Common questions about MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on June 3, 2026 before market open.
MIRA Pharmaceuticals, Inc. has approximately 6 employees.